| Literature DB >> 33050111 |
Dimitra Rafailia Bakaloudi1, Antonios Siargkas1, Kalliopi Anna Poulia2, Evangelia Dounousi3, Michail Chourdakis1.
Abstract
Chronic kidney disease (CKD) is associated with aggravating factors which can affect both body composition and nutritional status. The purpose of the present systematic review was to investigate the potential effects of any physical activity on body composition or nutritional status among patients with stage 5 CKD undergoing hemodialysis (HD). A literature search on PubMed, Scopus, Web of Science, Google Scholar, and Cochrane was conducted and 14 randomized clinical trials were included. Skeletal muscle index and mid-arm muscular circumference increased after resistance exercise, and the results on body mass index, % body fat, and lean body mass varied. Serum albumin and C-reactive protein, in most cases, showed a slight increase and decrease, respectively. An improvement was also observed in body strength and overall performance status. The results suggest that physical activity can be beneficial for both the body composition and nutritional status of patients undergoing HD and can help in the prevention of sarcopenia. However, further research is needed mainly in the field of nutritional status.Entities:
Keywords: body composition; chronic kidney disease; hemodialysis; nutritional status; physical activity; sarcopenia
Mesh:
Substances:
Year: 2020 PMID: 33050111 PMCID: PMC7601723 DOI: 10.3390/nu12103071
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the study selection process.
Characteristics of included Studies.
| Identity | Exercise Type | Strength Assessment Tool | Performance Status Assessment | Body Composition Assessment Tool | Participants Exercise Group | Female/Male Exercise Group | Mean Age Exercise Group (Years) | Participants Control Group | Female/Male Control Group | Mean Age Control Group (Years) |
|---|---|---|---|---|---|---|---|---|---|---|
| Abreu et al. [ | Resistance exercise | N/A | N/A | Circumferences and skinfold thickness | 25 | 54.5%/45.5% | 45.7 ± 15.2 | 19 | 61.5%/38.5% | 42.5 ± 13.5 |
| Cheema et al. [ | Resistance exercise | HGS 1 | 6MWT | Computed tomography and standard protocols by dietician | 24 | 7/17 | 60.0 ± 5.3 | 25 | 8/17 | 65.0 ± 12.9 |
| Chen et al. [ | Resistance exercise | ΝA | NA | DEXA | 22 | 10/12 | 71.1 ± 12.6 | 22 | 11/11 | 66.9 ± 13.4 |
| Cheng et al. [ | Resistance exercise | N/A | 6MWT | N/A | 67 | 28/39 | 54.6 ± 12.6 | 65 | 25/40 | 55.8 ± 11.98 |
| Cooke et al. [ | Aerobic exercise | HGS 2 | 6 m course as quickly as possible | N/A | 10 | 3/7 | 58.2 ± 17.2 | 10 | 3/7 | 52.5 ± 15.4 |
| Frih et al. [ | Resistance training | HGS 3 | 6MWT | N/A | 21 | 0/21 | 64.2 ± 3.4 | 20 | 0/20 | 65.2 ± 3.1 |
| Groussard et al. [ | Aerobic exercise | NA | 6MWT | DEXA | 8 | 3/5 | 66.5 ± 4.6 | 10 | 3/7 | 68.4 ± 3.7 |
| Johan-sen et al. [ | Resistance exercise | HGS 4 | Walking 6 m at their usual pace and as fast as possible | DEXA | 20 | 8/12 | 54.4 ± 13.6 | 20 | 6/14 | 56.8 ± 13.8 |
| Kopple, et al. [ | Aerobic exercise | N/A | N/A | DEXA | 10 | 4/6 | 45.9 ± 4.1 | 14 | 5/9 | 41.3 ± 3.3 |
| Kopple et al. [ | Resistance training | N/A | N/A | DEXA | 15 | 6/9 | 46.0 ± 2.7 | 14 | 5/9 | 41.3 ± 3.3 |
| Kopple et al. [ | Combined exercise | N/A | N/A | DEXA | 12 | 5/7 | 42.7 ± 3.8 | 14 | 5/9 | 41.3 ± 3.3 |
| Liao et al. [ | Aerobic exercise | N/A | 6MWT | DEXA | 20 | 12/8 | 62 ± 8 | 20 | 11/9 | 62 ± 9 |
| Lopes et al. [ | Resistance exercise (moderate load) | HGS | N/A | DEXA | 14 | 6/8 | 48.1 ± 10.8 | 20 | 1/13 | 56.9 ± 12.4 |
| Lopes et al. [ | Resistance exercise (heavy load) | HGS | N/A | DEXA | 16 | 7/9 | 56.2 ± 12.5 | 20 | 1/13 | 56.9 ± 12.4 |
| Marinho et al. [ | Resistance exercise | N/A | N/A | BCM | 6 | 3/3 | 71.5 (58.5–87.2) * | 7 | 4/3 | 76.0 (59.0-83.0) * |
| Olvera-Soto et al. [ | Resistance exercise | HGS 5 | N/A | Circumferences and skinfolds | 30 | 16/14 | 28.5 (23–46.5) * | 31 | 12/2019 | 29 (19–38) * |
| Rosa et al. [ | Resistance exercise | Wells Bench test | 6MWT | DEXA | 28 | 8/2020 | 54.5 ± 11.97 | 24 | 9/15 | 57.10 ± 16.20 |
| Silva et al. [ | Aerobic exercise | N/A | N/A | N/A | 14 | 7/7 | 50 ± 17.2 | 14 | 6/8 | 58 ± 15.0 |
| Song et al. [ | Resistance exercise | HGS 6 | N/A | InBody s107 | 20 | 12/8 | 52.1 ± 12.4 | 20 | 8/12 | 54.6 ± 10.1 |
| Suhardjonoc et al. [ | Aerobic exercise | HGS 6 | walk 4 m back and forth for an 8 m distance | BIA | 42 | 14/28 | 49.8 ± 11.7 | 39 | 21/18 | 50.5 ± 10.8 |
| Suhardjonoc et al. [ | Combined exercise | HGS 6 | walk 4 m back and forth for a total distance of 8 m | BIA | 39 | 21/18 | 50.5 ± 10.8 | 39 | 21/18 | 50.5 ±10.8 |
| Wilund et al. [ | Aerobic exercise | N/A | N/A | N/A | 7 | 4/3 | 60.8 ± 3.2 | 8 | 5/3 | 59.0 ± 4.9 |
N/A: not applicable; 6MWT: 6 min walk test; BC: body composition; DEXA: dual-energy X-ray absorptiometry, BIA: bioimpedance analysis (Maltron Inc., BioScan 920 2S Multifrequency Analyzer); BCM: body composition monitor; HGS: handgrip strength; *,#,@ same control group; 1 isometric digital dynamometer (Chatillon CSD 200; Dynamometer; Ametek Inc, Paoli, PA; CV, 9.4%); 2 hand dynamometer (Lafayette Instrument, Lafayette, IN); 3 dynamometer (T.K.K. 5401 GRIP D, Takei Science; Instruments, Niigata, Japan); 4 computerized dynamometer (Cybex Inc., Ronkonkoma, NY); 5 Analogue Handgrip Dynamometer Takei TKK 5001 Tokyo, Japan; 6 Jamar Hydraulic Hand Dynamometer; 7 Biospace, Seoul, Korea. Values are presented as: mean ± SD. * Median (interquartile range).
Figure 2Risk of bias graph of included studies.
Figure 3Risk of bias summary for included studies.
Results on BMI after intervention.
| Identity | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|
| Abreu et al. [ | 23.9 ± 4.7 | 23.8 ± 4.5 | Not reported | 24.4 ± 4.8 | 24.1 ± 4.9 | Not reported | >0.05 |
| Cheema et al. [ | 27.0 ± 6.0 | Not reported | 0.3 ± 0.5 | 28.0 ± 5.7 | Not reported | 0.1 ± 0.5 | 0.02 |
| Cooke et al. [ | 25.6 ± 4.3 | Not reported | 0.28 (−0.23–0.95) | 27.2 ± 6.1 | Not reported | 0.20 (−0.03–0.45) | 0.485 |
| Groussard et al. [ | 29.4 ± 2.1 | 29.5 ± 1.9 | Not reported | 26.5 ± 1.8 | 26.2 ± 1.9 | Not reported | >0.05 |
| Kopple et al. [ | 26.9 ± 1.9 | 26.6 ± 1.8 | Not reported | 24.9 ± 1.1 | 25.1 ± 1.2 | Not reported | >0.05 |
| Kopple et al. [ | 28.7 ± 2.5 | 27.7 ± 2.5 | Not reported | 24.9 ± 1.1 | 25.1 ± 1.2 | Not reported | >0.05 |
| Kopple et al. [ | 26.2 ± 1.5 | 26.0 ± 1.5 | Not reported | 24.9 ± 1.1 | 25.1 ± 1.2 | Not reported | >0.05 |
| Liao et al. [ | 22.9 ± 3.3 | 22.96 ± 3.36 | Not reported | 23.67 ± 4.16 | 23.91 ± 5.27 | Not reported | 0.054 |
| Marinho et al. [ | 28.5 (21.1–35.8) | 28.4 (21.8–36.2) | Not reported | 28.4 (20.8–35.2) | 28.6 (23.6–35.2) | Not reported | >0.05 |
| Rosa et al. [ | 26.4 ± 4.48 | 26.6 ± 4.44 | Not reported | 25.54 ± 3.95 | 25.5 ± 4.03 | Not reported | 0.752 |
| Wilund et al. [ | 30.1 ± 2.4 | 30.3 ± 2.5 | Not reported | 29.0 ± 2.0 | 28.3 ± 1.8 | Not reported | <0.05 |
a Same control group; variables displayed as mean ± SD, median (interquartile range). a: Resistance exercise; b: combined exercise; c: aerobic exercise. a,b,c: same control group.
Results on MAMC.
| Identity | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|
| Abreu et al. [ | 32.3 ± 14.6 | 33.9 ± 14.7 | Not reported | 35.6 ± 12.4 | 34.9 ± 15.2 | Not reported | >0.05 |
| Cheema et al. [ | 30.1 ± 4.0 | Not reported | 0.4 ± 1.4 | 30.1 ± 4.0 | Not reported | −0.6 ± 0.9 | 0.004 |
| Olvera-Soto et al. [ | 23.4 (20.3–25.4) | 24.1 (20.3–26.5) | 2.15 (−0.25 to 4.84) * | 22.6 (19.7–25.2) | 22.5 (19.6–25.5) | 0.67 (−1.35 to 2.87) * | <0.01 |
| Song et al. [ | 23.4 ± 1.4 | 23.5 ± 1.4 | 0.1 ± 0.7 | 23.7 ± 2.7 | 23.8 ± 2.6 | 0.0 ± 0.6 | 0.747 |
Variables displayed as the mean ± SD, median (interquartile range); * percentage (interquartile range).
Effects on Body Fat.
| Identity | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|
| Chen et al. [ | 31.3 ± 10.4 | 29.6 ± 9.8 | Not reported | 30.8 ± 11.2 | 33.1 ± 10.1 | Not reported | 0.9 |
| Groussard et al. [ | 32.2 ± 3.1 | 32.4 ± 3.2 | Not reported | 27.2 ± 2.7 | 27.3 ± 2.8 | Not reported | >0.05 |
| Johansen et al. [ | 22.4 ± 11.3 | 24.5 ± 11.1 | 2.2 ± 2.9 | 21.3 ± 11.9 | 21.4 ± 12.1 | 0.2 ± 1.6 | 0.05 |
| Kopple et al. [ | 27.3 ± 3.0 | 26.8 ± 3.4 | Not reported | 24.3 ± 2.5 | 25.1 ± 2.6 | Not reported | <0.01 |
| Kopple et al. [ | 23.5 ± 2.6 | 23.7 ± 2.6 | Not reported | 24.3 ± 2.5 | 25.1 ± 2.6 | Not reported | <0.01 |
| Kopple et al. [ | 28.3 ± 2.6 | 27.1 ± 2.8 | Not reported | 24.3 ± 2.5 | 25.1 ± 2.6 | Not reported | <0.01 |
| Lopes et al. [ | 20.0 ± 2.5 | 19.9 ± 2.5 | Not reported | 24.7 ± 2.1 | 24.6 ± 2.1 | Not reported | 0.69 |
| Lopes et al. [ | 23.7 ± 2.3 | 23.3 ± 2.3 | Not reported | 24.7 ± 2.1 | 24.6 ± 2.1 | Not reported | 0.69 |
| Marinho et al. [ | 47.4 (33.6–48.8) | 46.8 (35.0-48.6) | Not reported | 53.0 (42.1–54.8) | 52.1 (45.5–55.3) | Not reported | >0.05 |
| Olvera-Soto et al. [ | 16 (12.2–21.1) | 16.8 (13.1–20.3) | 5.43 (0.0 to 5.21) * | 14 (9.4–18.3) | 14.3 (11.3–18.8) | 0.42 (−13.2 to 7.97) * | 0.03 |
| Rosa et al. [ | 23.8 ± 9.21 | 23.10% ± 8.40 | Not reported | 23.15 ± 8.98 | 21.92 ±8.81 | Not reported | 0.619 |
| Song et al. [ | 27.5 ± 9.4 | 26.0 ± 8.6 | −1.5 ± 3.7 | 26.0 ± 9.3 | 27.2 ± 8.9 | 1.2 ± 3.8 | 0.020 |
a,b Same control group; variables displayed as the mean ± SD, median (interquartile range); * percentage (interquartile range). a: Resistance exercise; b: Combined exercise; c: Aerobic exercise. A: Resistance exercise (moderate load); B: Resistance exercise (heavy load). a, b, c: same control group. A, B: same control group 3.4. Lean body mass.
Effects on Lean Body Mass (kg).
| Identity | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|
| Chen et al. [ | 45.8 ± 8.9 | 47.9 ± 9.9 | Not reported | 47.8 ± 9.0 | 46.3 ± 8.7 | Not reported | 0.5 |
| Johansen et al. [ | 47.5 ± 12.3 | 47.1 ± 11.2 | −0.3 ± 3.0 | 48.4 ± 8.2 | 48.2 ± 8.8 | −0.1 ± 1.6 | 0.66 |
| Kopple et al. [ | 52.1 ± 0.28 | 51.4 ± 0.27 | Not reported | 47.7 ± 0.27 | 48.4 ± 0.26 | Not reported | >0.05 |
| Kopple et al. [ | 47.3 ± 0.26 | 47.7 ± 0.27 | Not reported | 47.7 ± 0.27 | 48.4 ± 0.26 | Not reported | >0.05 |
| Kopple et al. [ | 48.0 ± 0.33 | 48.5 ± 0.32 | Not reported | 47.7 ± 0.27 | 48.4 ± 0.26 | Not reported | >0.05 |
| Lopes et al. [ | 39.1 ± 2.1 | 39.4 ± 2.2 | Not reported | 41.6 ± 1.8 | 41.5 ± 1.8 | Not reported | 0.60 |
| Lopes et al. [ | 41.6 ± 0.8 | 41.9 ± 0.8 | Not reported | 41.6 ± 1.8 | 41.5 ± 1.8 | Not reported | 0.60 |
| Marinho et al. [ | 34.7 (32.3–53.3) | 35.7 (32.8–50.3) | Not reported | 24.4 (18.9–39.0) | 27.4 (23.8–34.0) | Not reported | >0.05 |
| Rosa et al. [ | 46.55 ± 9.03 | 47.55 ± 9.49 | Not reported | 43.48 ± 8.02 | 44.04 ± 8.23 | Not reported | 0.277 |
| Song et al. [ | 21.4 ± 3.6 | 22.2 ± 3.7 | 0.8 ± 1.0 | 22.8 ± 5.3 | 22.5 ± 5.2 | −0.3 ± 1.1 | 0.002 |
a,b Same control group, * skeletal body mass, variables displayed as the mean ± SD, median (interquartile range). a: Resistance exercise; b: Combined exercise; c: Aerobic exercise. A: Resistance exercise (moderate load); B: Resistance exercise (heavy load). a, b, c: same control group. A, B: same control group.
Effects on SMI (kg/m2).
| Identity | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|
| Lopes et al. [ | 6.4 ± 1.2 | 6.6 ± 1.2 | Not reported | 6.8 ± 1.03 | 6.6 ± 1.1 | Not reported | <0.01 |
| Lopes et al. [ | 6.7 ± 1.2 | 6.8 ± 1.1 | Not reported | 6.8 ± 1.03 | 6.6 ± 1.1 | Not reported | <0.01 |
| Suhardjono et al. [ | Males 10.4 ± 1.16 | Not reported | 0.15 | Males 9.92 ± 1.46 | Not reported | 0.01 | >0.05 |
| Suhardjono et al. [ | Males 9.92 ± 1.46 | Not reported | 0.04 | Males 9.92 ± 1.46 | Not reported | 0.01 | >0.05 |
a,b Same control group; variables displayed as the mean ± SD or median (min–max). a: Resistance exercise (moderate load); b: Resistance exercise (heavy load). a, b: same control group. A: Combined exercise; B; Aerobic exercise. A, B: same control group. 3.6. Serum Albumin and C-Reaction Protein
Changes in sALB (g/dl) and CRP (mg/L).
| Identity | Parameter | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | ||
|---|---|---|---|---|---|---|---|---|---|
| Abreu et al. [ | sALB | 4.3 ± 0.3 | 4.3 ± 0.3 | Not reported | 4.2 ± 0.2 | 4.2 ± 0.2 | Not reported | ||
| CRP | 7.7 ± 6.0 | 5.8 ± 4.4 | 8.54 ± 4.2 | 8.4 ± 7.5 | >0.05 | ||||
| Cheema et al. [ | sALB | 3.45 ± 0.31 | Not reported | 0.03 ± 0.24 | 3.36 ± 0.79 | Not reported | 0.01 ± 0.24 | 0.45 | |
| CRP | 0.78 ± 0.60 | −0.08 ± 0.37 | 0.72 ± 0.55 | 0.24 ± 0.37 | 0.02 | ||||
| Cheng et al. [ | sALB | 4.05 ± 0.27 | 4.09 ± 0.18 | Not reported | 3.96 ± 0.32 | 4.02 ± 0.36 | Not reported | 0.747 | |
| hs-CRP | 0.25 (0.08–0.37) | 0.15 (0.06–0.55) | 0.28 (0.16–0.43) | 0.26 (0.15–0.52) | |||||
| Frih et al. [ | sALB | 3.96 ± 0.35 | 0.40 ± 0.26 | Not reported | 3.99 ± 0.37 | 4.04 ± 0.37 | Not reported | ||
| CRP | 4.1 ± 1.3 | 4.1 ± 1.3 | 4.1 ± 1.1 | 4.0 ± 1.4 | >0.05 | ||||
| Kopple et al. [ | sALB | 3.7 ± 0.1 | 3.8 ± 0.1 | Not reported | 3.9 ± 0.1 | 3.9 ± 0.1 | Not reported | >0.05 | |
| CRP | 4.5 ± 1.5 | 2.5 ± 0.6 | 2.1 ± 0.4 | 2.8 ± 0.8 | |||||
| Kopple et al. [ | sALB | 3.9 ± 0.1 | 3.8 ± 0.1 | Not reported | 3.9 ± 0.1 | 3.9 ± 0.1 | Not reported | ||
| CRP | 3.5 ± 0.8 | 4.2 ± 1.3 | 2.1 ± 0.4 | 2.8 ± 0.8 | >0.05 | ||||
| Kopple et al. [ | sALB | 3.8 ± 0.1 | 3.8 ± 0.1 | Not reported | 3.9 ± 0.1 | 3.9 ± 0.1 | Not reported | ||
| CRP | 4.6 ± 1.4 | 5.8 ± 2.1 | 2.1 ± 0.4 | 2.8 ± 0.8 | >0.05 | ||||
| Liao et al. [ | sALB | 3.89 ± 0.33 | 4.16 ± 0.30 | Not reported | 4.00 ± 0.35 | 4.01 ± 0.42 | Not reported | ||
| Hs-CRP | 1.25 ± 2.01 | 0.78 ± 0.83 | 1.24 ± 2.04 | 1.23 ± 0.21 | <0.05 | ||||
| CRP | 0.7 ± 0.33 | 0.6 ± 0.20 | 1.2 ± 0.97 | 1.5 ± 0.89 | <0.01 | ||||
| Wilund et al. [ | CRP | 5.2 ± 0.78 | 4.9 ± 0.69 | Not reported | 6.2 ± 0.22. | 6.0 ± 0.67 | Not reported | <0.05 | |
| sALB | 3.9 ± 0.14 | 3.9 ± 0.15 | 3.8 ± 0.09 | 3.8 ± 0.06 | |||||
sALB: serum Albumin, CRP: C-Reactive Protein, Hs-CRP: high sensitivity C-Reactive Protein; a same control group; variables displayed as the mean ± SD or the median (interquartile range). a: Resistance exercise; b: Combined exercise; c: Aerobic exercise. a, b, c: same control group
Results of the strength evaluation.
| Identity | Parameter | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|---|
| Cheema et al. [ | Total strength | 98.1 ± 36.6 | Not reported | 15.2 ± 15.4 | 86.0 ± 33.8 | Not reported | −2.4 ± 13.8 | 0.002 |
| Chen et al. [ | Knee extensors strength (kg) | 11.4 ± 5.0 | 15.8 ± 5.0 | Not reported | 14.8 ± 6.0 | 12.1 ± 6.1 | Not reported | 0.08 |
| Cooke et al. [ | HGS | 23.2 ± 10.5 | Not reported | 1.3 (−0.5, 6.5) | 25.9 ± 13.8 | Not reported | 2.5 (−0.5, 4.0) | 0.464 |
| Frih et al. [ | Handgrip | 29.8 ± 6.0 | 37.4 ± 4.8 | Not reported | 29.3 ± 5.6 | 30 ± 5.2 | Not reported | <0.05 |
| Johansen et al. [ | Knee extension 3RM (lb) | 14.0 ± 8.4 | 22.6 ± 11.6 | 8.6 ± 6.9 | 19.2 ± 8.7 | 20.0 ± 9.1 | 0.8 ± 2.0 | <0.0001 |
| Hip abduction 3RM (lb) | 8.5 ± 5.2 | 15.4 ± 6.9 | 6.9 ± 5.0 | 11.8 ± 4.3 | 11.8 ± 5.9 | −0.1 ± 2.5 | <0.0001 | |
| Hip flexion 3RM (lb) | 7.6 ± 5.3 | 13.7 ± 6.8 | 6.1 ± 4.3 | 10.9 ± 4.5 | 11.4 ± 6.3 | 0.5 ± 2.7 | <0.0001 | |
| Lopes a et al. [ | HGS (kg) | 29.2 ± 10.2 | 32.1 ± 11.4 | Not reported | 25.3 ± 9.1 | 25.4 ± 9.9 | Not reported | 0.60 |
| Lopes a et al. [ | HGS (kg) | 30.0 ± 8.7 | 29.9 ± 10.1 | Not reported | 25.3 ± 9.1 | 25.4 ± 9.9 | Not reported | 0.60 |
| Olveira-Soto et al. [ | HGS (kg) | 19.6 (11–28) | 21.2 (13–32) | Not reported | 19.8 (14-26) | 17.8 (15-26) | Not reported | <0.01 |
| Rosa et al. [ | HGS (kg/strength) | 65.7 ± 23.3 | 66.61 ± 22.22 | Not reported | 59.21 ± 20.66 | 58.52 ± 18.19 | Not reported | 0.213 |
| Song et al. [ | HGS (kg) | 26.3 ± 8.5 | 28.7 ± 9.0 | 2.4 ± 2.8 | 26.2 ± 10.2 | 27.8 ± 11.8 | 1.6 ± 4.0 | 0.465 |
| Leg muscle strength (kg) | 33.0 ± 15.3 | 37.3 ± 19.0 | 4.3 ± 8.7 | 34.8 ± 20.3 | 33.4 ± 19.5 | −1.4 ± 7.0 | 0.027 | |
| Suhardjono b et al. [ | HGS (kg) | Males: 24.8 ± 9.19 | Not reported | −0.08 | Males: 22.1 ± 9.26 | Not reported | −0.1 | >0.05 |
| Suhardjono b et al. [ | HGS (kg) | Males: 21.6 ± 8.84 | Not reported | 0 | Males: 22.1 ± 9.26 | Not reported | −0.1 | >0.05 |
HGS: Handgrip strength; RM: repetition maximum; a,b same control group; variables displayed as the mean ± SD, median (interquartile range), median (min–max). a: Resistance exercise (moderate load); b: Resistance exercise (heavy load). a, b: same control group. A: Combined exercise; B; Aerobic exercise. A, B: same control group.
Changes on performance status.
| Identity | Test Used | Exercise Group Before | Exercise Group After | Exercise Group Change | Control Group Before | Control Group After | Control Group Change | |
|---|---|---|---|---|---|---|---|---|
| Cheema et al. [ | 6MWT (m) | 496.0 ± 138.9 | Not reported | 19.6 ± 4.0 | 412.6 ± 138.9 | Not reported | 1.5 ± 23.7 | 0.16 |
| Cheng et al. [ | 6MWT (m) | 439.1 ± 85.5 | 490.5 ± 70.3 | Not reported | 460.3 ± 79.1 | 456.7 ± 94.1 | Not reported | 0.207 |
| Cooke et al. [ | 6 m course as quickly as possible (m/s) | 0.8 ± 0.2 | Not reported | 0.02 | 0.9 ± 0.3 | Not reported | −0.11 | 0.158 |
| Frih et al. [ | 6MWT (m) | 420 ± 35.1 | 480.5 ± 31.9 | Not reported | 422.2 ± 26.6 | 415.6 ± 36.3 | Not reported | <0.05 |
| Groussard et al. [ | 6MWT (m) | 406 ± 18 | 500 ± 30 | Not reported | 376 ± 20 | 406 ± 18 | Not reported | <0.001 |
| Johansen et al. [ | Walking 6m at their usual pace and as fast as possible (gait speed-cm/s) | 100.9 ± 35.5 | 103.5 ± 34.2 | 2.7 ± 17.3 | 99.8 ± 31.5 | 105.7 ± 31.1 | 6.0 ± 17.2 | 0.71 |
| Rosa et al. [ | 6MWT (m) | 506.1 ± 130.3 | 526.5 ± 126.2 | Not reported | 452.65 ± 169.19 | 469.4 ± 162.9 | Not reported | 0.277 |
| Suhardjono et al. [ | Walk 4 m back and forth for a total distance of 8 m (m/s) | Males: 0.86 ± 0.25 | Not reported | 0.08 ± 0.16 | Males: 0.8 ± 0.25 | Not reported | 0.07 ± 0.19 | >0.05 |
| Suhardjono et al. [ | Walk 4 m back and forth for a total distance of 8 m (m/s) | Males: 0.87 ± 0.19 | Not reported | 0.10 ± 0.12 | Males: 0.8 ± 0.25 | Not reported | 0.07 ± 0.19 | >0.05 |
6MWT: 6 min walk test; variables displayed as the mean ± SD or median (interquartile range). a: Combined exercise; b: Aerobic exercise. a, b: same control group.